Onco-D-Clare Plus

Cancel Cancer.
Before It Even Reveals itself.

Onco-D-clare detects molecular disease activity long before a tumour's visible on a scan.

What is Onco-D–clare Plus?

What it Does: This early screening test detects cancerous cells long before symptoms manifest. This liquid biopsy cancer screening test uses state-of-the-art technology that merges molecular biology with artificial neural networks.

What it Means: Allows you to stay informed about your risk and take proactive lifestyle changes.

Who's it For: Anyone who does not have a cancer diagnosis.

How Does It Work?

The 10-year gap.

A tumor typically grows silently for years - as much as 10 years - reaching 1 billion cells (approx. 1cm) before standard imaging detects it.
.

Immune Frame Profiling

Did you know that your immune system knows that cancer is there years before a scan does?

We use Immune-frame Profiling to read your immune signals to catch the disease in the "Silent Phase" - long before it becomes a visible crisis.

Test Components

Peripheral Blood Mononuclear Cells (PBMCs)

Peripheral Blood Mononuclear Cells (PBMCs) are key players in your immune system, including T cells, B cells, NK cells, and monocytes. These cells are responsible for identifying and responding to abnormal cells in your body, including cancer cells.By analyzing the gene expression of these PBMCs, we can detect the earliest signs of cancer before it even becomes visible in other tests.